These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18058471)

  • 1. CYR61: a new measure of lung cancer outcome.
    Mori A; Desmond JC; Komatsu N; O'Kelly J; Miller CW; Legaspi R; Marchevsky AM; McKenna RJ; Koeffler HP
    Cancer Invest; 2007 Dec; 25(8):738-41. PubMed ID: 18058471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.
    Xie D; Nakachi K; Wang H; Elashoff R; Koeffler HP
    Cancer Res; 2001 Dec; 61(24):8917-23. PubMed ID: 11751417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer.
    Chen PP; Li WJ; Wang Y; Zhao S; Li DY; Feng LY; Shi XL; Koeffler HP; Tong XJ; Xie D
    PLoS One; 2007 Jun; 2(6):e534. PubMed ID: 17579708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas.
    Xie D; Yin D; Wang HJ; Liu GT; Elashoff R; Black K; Koeffler HP
    Clin Cancer Res; 2004 Mar; 10(6):2072-81. PubMed ID: 15041728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
    Holloway SE; Beck AW; Girard L; Jaber MR; Barnett CC; Brekken RA; Fleming JB
    J Am Coll Surg; 2005 Mar; 200(3):371-7. PubMed ID: 15737847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
    Sampath D; Winneker RC; Zhang Z
    Endocrinology; 2001 Jun; 142(6):2540-8. PubMed ID: 11356703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of CYR61 and VEGF in extranodal nasal-type NK/T cell lymphoma and their significances].
    Tang QL; Liu WP; Zhang WY; Yang F; He MX; Xia QJ; Li GD
    Zhonghua Xue Ye Xue Za Zhi; 2006 Oct; 27(10):661-5. PubMed ID: 17343196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway.
    Lin MT; Zuon CY; Chang CC; Chen ST; Chen CP; Lin BR; Wang MY; Jeng YM; Chang KJ; Lee PH; Chen WJ; Kuo ML
    Clin Cancer Res; 2005 Aug; 11(16):5809-20. PubMed ID: 16115920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway.
    Tong X; O'Kelly J; Xie D; Mori A; Lemp N; McKenna R; Miller CW; Koeffler HP
    Oncogene; 2004 Jun; 23(28):4847-55. PubMed ID: 15077166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.
    Sakamoto S; Yokoyama M; Zhang X; Prakash K; Nagao K; Hatanaka T; Getzenberg RH; Kakehi Y
    Endocrinology; 2004 Jun; 145(6):2929-40. PubMed ID: 14988385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premenstrual regulation of the pro-angiogenic factor CYR61 in human endometrium.
    Gashaw I; Stiller S; Böing C; Kimmig R; Winterhager E
    Endocrinology; 2008 May; 149(5):2261-9. PubMed ID: 18202125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyr61 protects against hyperoxia-induced cell death via Akt pathway in pulmonary epithelial cells.
    Jin Y; Kim HP; Ifedigbo E; Lau LF; Choi AM
    Am J Respir Cell Mol Biol; 2005 Sep; 33(3):297-302. PubMed ID: 15961723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyr61 promotes breast tumorigenesis and cancer progression.
    Tsai MS; Bogart DF; Castañeda JM; Li P; Lupu R
    Oncogene; 2002 Nov; 21(53):8178-85. PubMed ID: 12444554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
    Watari H; Xiong Y; Hassan MK; Sakuragi N
    Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of quantitative detection assays for CYR61 as a new marker for benign prostatic hyperplasia.
    Sakamoto S; Yokoyama M; Prakash K; Tsuruha J; Masamoto S; Getzenberg RH; Kakehi Y
    J Biomol Screen; 2003 Dec; 8(6):701-11. PubMed ID: 14711396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury.
    Muramatsu Y; Tsujie M; Kohda Y; Pham B; Perantoni AO; Zhao H; Jo SK; Yuen PS; Craig L; Hu X; Star RA
    Kidney Int; 2002 Nov; 62(5):1601-10. PubMed ID: 12371960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways.
    Han JS; Macarak E; Rosenbloom J; Chung KC; Chaqour B
    Eur J Biochem; 2003 Aug; 270(16):3408-21. PubMed ID: 12899698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma.
    Walker TM; Van Ginkel PR; Gee RL; Ahmadi H; Subramanian L; Ksander BR; Meisner LF; Albert DM; Polans AS
    Arch Ophthalmol; 2002 Dec; 120(12):1719-25. PubMed ID: 12470148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and function of CYR61 (CCN1) in prostatic stromal and epithelial cells: CYR61 is required for prostatic cell proliferation.
    Sakamoto S; Yokoyama M; Aoki M; Suzuki K; Kakehi Y; Saito Y
    Prostate; 2004 Dec; 61(4):305-17. PubMed ID: 15389821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.